286 related articles for article (PubMed ID: 18930252)
1. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family.
Liu JY; Guo YJ; Zhou CK; Ye YQ; Feng JQ; Yin F; Jiang XM
J Neurol Sci; 2011 May; 304(1-2):83-6. PubMed ID: 21397913
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
4. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
[TBL] [Abstract][Full Text] [Related]
5. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
6. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
7. An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.
Frigerio R; Fabrizi GM; Ferrarini M; Cavallaro T; Brighina L; Santoro P; Agostoni E; Cavaletti G; Rizzuto N; Ferrarese C
Amyloid; 2004 Jun; 11(2):121-4. PubMed ID: 15478468
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
9. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
[TBL] [Abstract][Full Text] [Related]
10. Familial amyloid polyneuropathy: a clinico-pathologic study.
Said G; Planté-Bordeneuve V
J Neurol Sci; 2009 Sep; 284(1-2):149-54. PubMed ID: 19467548
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
[TBL] [Abstract][Full Text] [Related]
13. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
14. Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Obayashi K; Ueda M; Oshima T; Kawahara S; Misumi Y; Yamashita T; Jono H; Yazaki M; Kametani F; Ikeda S; Ohya Y; Asonuma K; Inomata Y; Ando Y
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907857
[TBL] [Abstract][Full Text] [Related]
15. Pathology of familial amyloidotic polyneuropathy with TTR met 30 in Kumamoto, Japan.
Araki S; Yi S
Neuropathology; 2000 Sep; 20 Suppl():S47-51. PubMed ID: 11037187
[TBL] [Abstract][Full Text] [Related]
16. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
[TBL] [Abstract][Full Text] [Related]
17. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54.
Togashi S; Watanabe H; Nagasaka T; Shindo K; Shiozawa Z; Maeda S; Tawata M; Onaya T
Neurology; 1999 Aug; 53(3):637-9. PubMed ID: 10449136
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset.
Russo M; Mazzeo A; Stancanelli C; Di Leo R; Gentile L; Di Bella G; Minutoli F; Baldari S; Vita G
J Peripher Nerv Syst; 2012 Dec; 17(4):385-90. PubMed ID: 23279339
[TBL] [Abstract][Full Text] [Related]
19. [Transthyretin familial amyloid polyneuropathy].
Kopishinskaya SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]